Univest
Univest
  • Markets
  • BSE vs NSE vs MCX vs IEX Shares: Which Exchange Stocks Look Stronger After Q2 Results? Profit Growth, Price Moves and Risks Compared

    • November 5, 2026
    • Posted by: Ankit Jaiswal
    • Category: Results
    No Comments
    BSE vs NSE vs MCX vs IEX Shares: Which Exchange Stocks Look Stronger After Q2 Results? Profit Growth, Price Moves and Risks Compared

    BSE vs NSE vs MCX vs IEX shares after Q2 results: compare profit growth, price moves and risks across exchange stocks.

    read more
  • MCX Share Price Falls on Profit Booking After Q2 Results Despite a 130% Profit Jump: What Is Next for the Exchange Stock?

    • November 4, 2026
    • Posted by: Ankit Jaiswal
    • Category: Results
    No Comments
    MCX Share Price Falls on Profit Booking After Q2 Results Despite a 130% Profit Jump: What Is Next for the Exchange Stock?

    MCX share price fell nearly 7% despite Q2 profit up 130%. See results, why profit booking hit the stock, dividend history, price levels and risks.

    read more
  • NSE Q2 Results FY27: Consolidated Profit Up 22.8% to Rs 2,577.6 Crore, and What the Base Effect Means for the Share

    • November 4, 2026
    • Posted by: Kunal Singla
    • Category: Results
    No Comments
    NSE Q2 Results FY27: Consolidated Profit Up 22.8% to Rs 2,577.6 Crore, and What the Base Effect Means for the Share

    NSE Q2 results FY27: consolidated profit rose 22.8% to Rs 2,577.6 crore on revenue of Rs 4,066.8 crore. See the base effect, dividend history and risks.

    read more
  • NSE Share Price Target: Morgan Stanley and JPMorgan Initiate Coverage With Overweight, See Up to 30% Upside, but the Stock Still Trades Below Its IPO Price of Rs 1,785

    • November 2, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    NSE Share Price Target: Morgan Stanley and JPMorgan Initiate Coverage With Overweight, See Up to 30% Upside, but the Stock Still Trades Below Its IPO Price of Rs 1,785

    NSE share price target: Morgan Stanley sets Rs 2,315 and JPMorgan Rs 2,130 with Overweight ratings, up to 30% upside. Stock is near its Rs 1,785 IPO price. Brokerage views, risks and what to watch.

    read more
  • NSE vs BSE: Why the Newly Listed Exchange Trades Below Its IPO Price While BSE Wins Derivatives Share, and Which Stock Fits Which Investor Before Q2 Results

    • October 5, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    NSE vs BSE: Why the Newly Listed Exchange Trades Below Its IPO Price While BSE Wins Derivatives Share, and Which Stock Fits Which Investor Before Q2 Results

    NSE vs BSE: compare profit, market share, valuation and risks for the two exchange stocks before Q2 results.

    read more
  • MCX Gets a Rs 98 Crore GST Demand for FY23, but the Stock Still Trades Near Its 52-Week High

    • October 1, 2026
    • Posted by: Lakshit Sharma
    • Category: News
    No Comments
    MCX Gets a Rs 98 Crore GST Demand for FY23, but the Stock Still Trades Near Its 52-Week High

    MCX received a Rs 98 crore GST demand for FY23, but the stock stayed near its 52-week high. Here is what the notice means and the risks.

    read more
  • BSE Share Price Dips 3% After Rs 2,186 Crore BSE Stake Sale by Goldman Sachs, BNP Paribas; UTI and Nippon MF Buy

    • September 30, 2026
    • Posted by: Chaitanya Auti
    • Category: News
    No Comments
    BSE Share Price Dips 3% After Rs 2,186 Crore BSE Stake Sale by Goldman Sachs, BNP Paribas; UTI and Nippon MF Buy

    BSE share price fell to Rs 3,075 on 30 September 2026 after Goldman Sachs and BNP Paribas sold a 1.67% stake worth Rs 2,186 crore in a BSE bulk deal. Buyers, targets and outlook.

    read more
  • BSE Shares Fall 2% as SEBI Weighs a Panel on Self-Listing Norms for Stock Exchanges

    • September 28, 2026
    • Posted by: Chaitanya Auti
    • Category: News
    No Comments
    BSE Shares Fall 2% as SEBI Weighs a Panel on Self-Listing Norms for Stock Exchanges

    BSE shares fell 2% on a report that SEBI may set up a panel on self-listing norms. Here are the levels, valuation and risks.

    read more